Top Markets
Coin of the day
Grace Therapeutics, Inc. Grace Therapeutics, Inc.

Grace Therapeutics, Inc.

GRCE
Ранг среди акций #27036
Grace Therapeutics, Inc. specializes in the creation and commercialization of... Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betamethasone spray intended for the management of ataxia-telangiectasia, and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. Established in 2002, the enterprise previously operated under the name Acasti Pharma Inc., before officially adopting Grace Therapeutics, Inc. in October 2024. The company's main offices are located in Princeton, New Jersey.
Цена акции
$2.18
Последняя синхронизация: 2026-08-19
Рыночная капитализация
$35.55M
Изменение (1 день)
2.57%
Изменение (1 год)
-33.19%
Страна
US
Торговля Grace Therapeutics, Inc. (GRCE)

Категория

История цены акций Grace Therapeutics, Inc. (GRCE)
Наивысшая цена закрытия: $2.13 2026-08-01

Наименьшая цена закрытия: $3.24 2024-10-01
История цены акций Grace Therapeutics, Inc. с 2024 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -5.78%
2025 -13.39%
2024 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$758.23 6.53%
CH